Image 1_Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma.tif

Background<p>Low-grade endometrial stromal sarcoma (LG-ESS) is a rare uterine malignancy characterized by its complex tumor microenvironment (TME) and high recurrence rates, posing challenges to accurate prognosis and effective treatment. Identifying prognostic biomarkers is essential for impr...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Yu Miao (224415) (author)
مؤلفون آخرون:	Meng Dong (731156) (author), Qiyin Zhou (530145) (author), Julia Thiel (4733850) (author), Na Li (6550) (author), Ying Cai (22305) (author), Dan Yuan (370629) (author), Haitao Wang (165102) (author), Su-Han Jin (6338594) (author), Hua Yang (120668) (author), Jinjing Wang (5068040) (author), Benjamin Frey (3553964) (author), Udo S. Gaipl (4907050) (author), Hu Ma (790453) (author), Jian-Guo Zhou (5754935) (author)
منشور في:	2024
الموضوعات:	Genetic Immunology scRNA-seq FGF12 low-grade endometrial stromal sarcoma tumor microenvironments prognostic biomarker
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Image 1_Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma.tif

مواد مشابهة